Blended learning for entrepreneurial biomedical professionals
Paul Janssen Futurelab Leiden offers a non-profit, international blended learning program for tomorrow’s leaders in biomedical science who have the ambition to develop a new medical intervention.
Featured course
Featured resource
Featured
white paper
Take the next step in your biomedical career
Do you have a great idea for a new medical product, but no idea where to start developing it? The trick is to find a post-graduate training program that is suited to your specific needs.
That's why we wrote a white paper about the Future4 approach to help you find the right post-graduate program by identifying the four key focus areas that will take your career to the next level.
Get access to our white paper
On-campus experience
Further explore the concepts of the online courses during the on-campus course. Maximum 30 participants are invited to castle Oud-Poelgeest near Leiden, the Netherlands to work in small, multidisciplinary focus groups on advanced teaching cases that are based on real R&D project.
Read more
A selection of our contributors
Juliane Bernholz
Chief Operating Officer
AM Pharma
Onno van de Stolpe
CEO
Galapagos B.V.
Marc Martens
Head of Bird & Bird's Regulatory, Public & Administrative Law group in Brussels
Bird & Bird
Aliki Nichogiannopoulou
Director
European Patent Office
Ton van der Hoven
CEO
SurgVision BV
Bruno Vandermeulen
IP Lawyer - Member of the Brussels Bar
Independent IP practitioner
On-campus
Nacer Lounis
Senior Principal Scientist
Janssen Pharmaceutica
On-campus
Tine de Marez
Senior Director, Compound Development Team Leader TB
Johnson & Johnson
Bert Leufkens
Professor of Pharmaceutical Policy and Regulatory Science and Former Chair of Medicines Evaluation Board
Utrecht Institute for Pharmaceutical Sciences (UIPS)
Henk Schuring
VP-Head Rare Nephrology
Sanofi Genzyme
Sjaak Bot
VP, Head of EMEA Regulatory Affairs
Janssen
Bernd van der Meulen
Professor of Comparative Food Law
European Institute for Food Law / Renmin University of China Law School
Frank Landolt
Chief Counsel Legal & Intellectual Property
Confo Therapeutics
On-campus
Erik Niks
Neurologist - Pediatric neurologist
Leiden University Medical Center
On-campus
Piet Hinoul
Global Head, Pre-Clinical, Clinical and Medical Affairs
J&J Ethicon
On-campus
Ad Sitsen
Owner
ClinPharMed Consultancy for Drug Development
Eline Bunnik
Assistant professor Medical Ethics and Philosophy of Medicine
Erasmus MC
Maurits Westerik
IE/IT lawyer
Coupry
Bart Swinkels
Partner
NLO
Karin Verzijden
Food and Pharma Lawyer
Axon Lawyers
On-campus
Ineke Jonker-Hoogerkamp
Consultant Regulatory Affairs and Drug Development
Paul Janssen Futurelab & Eagle Pharma Consult
Kees Recourt
Investment Manager
Mibiton Foundation
Paul Stoffels
Chief scientific officer
Johnson & Johnson
Tom Huizinga
Head of the Department of Rheumatology
Leiden University Medical Centre
On-campus
Marcel Kenter
Director
Paul Janssen Futurelab Leiden
On-campus
Koen Andries
VP Scientific Fellow Infectious Diseases Discovery
Janssen Pharmaceutica NV
On-campus
Andreas Wallnöfer
General Partner
BioMed Partners Venture Capital (former Head of Clinical Research & Exploratory Development at F. Hoffmann-La Roche Ltd.)
On-campus
Justin Hay
Pharmacokinetics Assessor
Medicines and Healthcare products Regulatory Agency
On-campus
André Elferink
Clinical epidemiologist
Dutch Medicines Evaluation Board
On-campus
Rob Zuiker
Senior Clinical Scientist
CHDR
Hans-Georg Eichler
Senior Medical Officer
European Medicines Agency
On-campus
Robert Klautz
Thoracic Surgeon
Leiden University Medical Centre
On-campus
Matthijs Moerland
Research Director Translational Biomarkers
CHDR
Joris Rotmans, MD, PhD
internist-nephrologist
LUMC
On-campus
Janneke Meulenberg
CEO
Arthrogen
Inge de Lepeleire
Director Translational Pharmacology
MSD Europe
On-campus
Koos Burggraaf
Research Director CVS & Metabolism
CHDR
Johan Garssen
Director Immunology Platform
Danone/Nutricia Research
On-campus
Ingrid de Visser
Senior Clinical Scientist
CHDR
Rick Kuntz
Senior Vice President and Chief Scientific, Clinical and Regulatory Officer
Medtronic
On-campus
Geert Jan Groeneveld
Research Director CNS
CHDR
Oliver Bisazza
Director Regulatory Policy
Medtronic
Saco de Visser
Teacher and Clinical Pharmacologist
Paul Janssen Futurelab Leiden
On-campus
Adam Cohen
CEO and clinical pharmacologist
Centre for Human Drug Research
Richard Shull
Head of Deal Structuring and Trading Fundamentals
Shell
Pierre Peeters
Former site head early stage development
Organon
Solid understanding
This course gives you a solid understanding of intellectual property which will allow you to efficiently interact with IP specialists. The content is comprehensive, the cases studies are very relevant and all is set in a nice digital environment.
Tim van Acker, VIB, Intellectual Property Online graduate
Excellent learning opportunities
The cases were excellent and the manner in which they were presented provided excellent learning opportunities.
Vickas Patel, GlaxoSmithKline, Clinical Development Online graduate
The only IP course you need
The only IP course you need to follow to further build upon in your career! Very clear and well organized with a very relevant and practical coaching approach.
Louis Declerck, Associate at Fund+
Challenging content
I thoroughly enjoyed this course! The content, consisting of great videos, articles, and assignments, both challenged and matched my knowledge of clinical development.
Jaap Sniekers, Novartis, Clinical Development Online graduate